Cargando…

The All-Stakeholders-Considered Case for Corporate Beneficence

In ways accentuated by the global coronavirus pandemic, corporations constitute vital instruments of the acts of beneficence needed by the people of the world to make progress in public health and increase collective and individual well-being. This article contributes to understanding the variety of...

Descripción completa

Detalles Bibliográficos
Autor principal: de los Reyes, Gastón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607729/
https://www.ncbi.nlm.nih.gov/pubmed/36320555
http://dx.doi.org/10.1007/s10551-022-05224-9
_version_ 1784818617550897152
author de los Reyes, Gastón
author_facet de los Reyes, Gastón
author_sort de los Reyes, Gastón
collection PubMed
description In ways accentuated by the global coronavirus pandemic, corporations constitute vital instruments of the acts of beneficence needed by the people of the world to make progress in public health and increase collective and individual well-being. This article contributes to understanding the variety of moral forces that may lead corporations to commit acts of beneficence, including Friedman’s business case for corporate beneficence, the duty of beneficence as developed by business ethicists, and Dunfee’s social contract account of corporate obligation. Whereas Mejia recently contributed to scholarship on corporate beneficence by expressly adopting shareholder primacy’s conception of corporate governance, this article embraces a stakeholder-oriented, managerialist picture of corporate governance. I extend the literature on beneficence by incorporating what I argue is the intuition underlying Dunfee’s contractualist formula of minimal contribution, namely that management’s duty to do good is awakened and unshackled to the extent management judges the corporation can afford to commit acts of beneficence, all stakeholders considered. The all-stakeholders-considered case for corporate beneficence compels management to act, I argue, when inaction would undermine the moral integrity of managers personally committed to promoting the well-being of humanity.
format Online
Article
Text
id pubmed-9607729
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-96077292022-10-28 The All-Stakeholders-Considered Case for Corporate Beneficence de los Reyes, Gastón J Bus Ethics Original Paper In ways accentuated by the global coronavirus pandemic, corporations constitute vital instruments of the acts of beneficence needed by the people of the world to make progress in public health and increase collective and individual well-being. This article contributes to understanding the variety of moral forces that may lead corporations to commit acts of beneficence, including Friedman’s business case for corporate beneficence, the duty of beneficence as developed by business ethicists, and Dunfee’s social contract account of corporate obligation. Whereas Mejia recently contributed to scholarship on corporate beneficence by expressly adopting shareholder primacy’s conception of corporate governance, this article embraces a stakeholder-oriented, managerialist picture of corporate governance. I extend the literature on beneficence by incorporating what I argue is the intuition underlying Dunfee’s contractualist formula of minimal contribution, namely that management’s duty to do good is awakened and unshackled to the extent management judges the corporation can afford to commit acts of beneficence, all stakeholders considered. The all-stakeholders-considered case for corporate beneficence compels management to act, I argue, when inaction would undermine the moral integrity of managers personally committed to promoting the well-being of humanity. Springer Netherlands 2022-10-27 /pmc/articles/PMC9607729/ /pubmed/36320555 http://dx.doi.org/10.1007/s10551-022-05224-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
de los Reyes, Gastón
The All-Stakeholders-Considered Case for Corporate Beneficence
title The All-Stakeholders-Considered Case for Corporate Beneficence
title_full The All-Stakeholders-Considered Case for Corporate Beneficence
title_fullStr The All-Stakeholders-Considered Case for Corporate Beneficence
title_full_unstemmed The All-Stakeholders-Considered Case for Corporate Beneficence
title_short The All-Stakeholders-Considered Case for Corporate Beneficence
title_sort all-stakeholders-considered case for corporate beneficence
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607729/
https://www.ncbi.nlm.nih.gov/pubmed/36320555
http://dx.doi.org/10.1007/s10551-022-05224-9
work_keys_str_mv AT delosreyesgaston theallstakeholdersconsideredcaseforcorporatebeneficence
AT delosreyesgaston allstakeholdersconsideredcaseforcorporatebeneficence